Atypical antipsychotics up renal injury risk in seniors

August 19, 2014
Atypical antipsychotics up renal injury risk in seniors

(HealthDay)—Use of atypical antipsychotic drugs is associated with increased risk of acute kidney injury (AKI) in older adults, according to research published in the Aug. 19 issue of the Annals of Internal Medicine.

Y. Joseph Hwang, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues analyzed data for 97,777 adults aged 65 years or older who received a new outpatient prescription for an oral atypical antipsychotic . These patients were matched 1:1 with a group of individuals who did not receive such a prescription. The authors sought to assess the risk of AKI and other adverse outcomes with the use of these agents.

The researchers found that risk of hospitalization for AKI was higher among older adults who used atypical antipsychotic agents compared with those who did not use these agents (relative risk [RR], 1.73; 95 percent confidence interval [CI], 1.55 to 1.92). When data were analyzed for a subpopulation of patients for whom information on serum creatinine levels was available, this association was consistently observed (5.46 versus 3.34 percent; RR, 1.70 [95 percent CI, 1.22 to 2.38]; absolute risk increase, 2.12 percent [95 percent CI, 0.80 to 3.43 percent]). Use of in older adults was also associated with increased risk of hypotension (RR, 1.91; 95 percent CI, 1.60 to 2.28), acute urinary retention (RR, 1.98; 95 percent CI, 1.63 to 2.40), and all-cause mortality (RR, 2.39; 95 percent CI, 2.28 to 2.50).

"The findings support current safety concerns about the use of these drugs in ," the authors write.

Explore further: Mild adverse events common with chiropractic care

More information: Full Text (subscription or payment may be required)

Related Stories

Mild adverse events common with chiropractic care

September 20, 2013

(HealthDay)—Adverse events are common after chiropractic care, but seem to be due to non-specific effects and are mostly benign, according to a study published in the Sept. 15 issue of Spine.

Melanoma risk up in IBD independent of biologic therapy

January 31, 2014

(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology ...

USPSTF says evidence doesn't support vitamin D screening

June 24, 2014

(HealthDay)—Current evidence is insufficient to weigh the benefits and harms of screening for vitamin D deficiency to improve health outcomes in asymptomatic adults, according to a draft evidence report from the U.S. Preventative ...

Biologic treatments for RA carry similar infection risk

July 28, 2014

(HealthDay)—The risk of hospitalized bacterial infections in older rheumatoid arthritis (RA) patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, according to a study ...

Recommended for you

Immune breakthrough: Unscratching poison ivy's rash

August 23, 2016

We all know that a brush with poison ivy leaves us with an itchy painful rash. Now, Monash University and Harvard researchers have discovered the molecular cause of this irritation. The finding brings us a step closer to ...

Zika infection may affect adult brain cells

August 18, 2016

Concerns over the Zika virus have focused on pregnant women due to mounting evidence that it causes brain abnormalities in developing fetuses. However, new research in mice from scientists at The Rockefeller University and ...

Monkeys with Sudan ebolavirus treated successfully

August 22, 2016

Scientists funded by the National Institutes of Health (NIH) have successfully treated monkeys several days after the animals were infected with Sudan ebolavirus (SUDV). The study is important, according to the researchers, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.